efficacy of antibodies and enhanced end result has long been seen along side higher affinity polymorphisms of Fc?RIIa/CD32a, which are not expressed on NK cells.27 This can be specially important within the context of procedure with daratumumab. At first, it was assumed that ADCC mediated by NK cells would constitute one of A very powerful mechanis